PUBLIC MARKS with tags american & research

The plain fact is that embryonic stem cell research is proving to be a bust. There are currently 72 therapies showing human benefits using adult stem cells and zero using embryonic stem cells. Scientifically-minded readers can review this medical journal article on the status of adult stem cell research. Adult stem cell therapies are already being advertised and promoted while no such treatments are even remotely in prospect for embryonic stem cell research.

Musings, links, and occasional rants by Rebecca MacKinnon, a recovering TV reporter-turned-blogger.

When Donald Kennedy, a biologist and editor of the eminent journal Science, was asked what had led so many American scientists to feel that George W. Bush's administration is anti-science, he isolated a familiar pair of culprits: climate change and stem cells. These represent, he said, ''two solid issues in which there is a real difference between a strong consensus in the science community and the response of the administration to that consensus.'' Both issues have in fact riled scientists since the early days of the administration, and both continue to have broad repercussions. In March 2001, the White House abruptly withdrew its support for the Kyoto Protocol on climate change, and the U.S. withdrawal was still a locus of debate at this summer's G8 summit in Scotland. And the administration's decision to limit federal funds for embryonic-stem-cell research four years ago -- a move that many scientists worry has severely hampered one of the most fruitful avenues of biomedical inquiry to come along in decades -- resulted in a shift in the dynamics of financing, from the federal government to the states and private institutions. In November 2004, Californians voted to allocate $3 billion for stem-cell research in what was widely characterized as a ''scientific secession.''